IntrinsicIntrinsic
← Scroll for more →

Financial Statements — MBOT

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents3.153.663.916.704.083.223.110.482.471.162.471.345.722.152.444.337.2910.4713.4913.43
Short-term Investments64.2268.8474.6873.4528.5927.172.363.864.005.193.926.824.202.915.762.002.002.002.005.00
Accounts Receivable0.180.11------------------------------------
Inventory2.912.260.58----------------------------------
Total Current Assets72.1776.5379.8280.7932.8930.665.825.007.147.007.928.4110.345.588.816.609.6512.7515.8818.79
Property, Plant & Equipment0.320.190.090.080.080.080.080.100.120.130.150.180.180.200.220.260.280.240.240.23
Total Non-current Assets*1.191.541.720.980.240.240.210.210.300.370.410.480.550.630.720.810.890.930.890.91
Total Assets73.3678.0781.5481.7633.1330.896.035.217.437.378.338.8910.886.219.547.4110.5413.6816.7719.70
Accounts Payable0.871.090.510.510.500.19--0.250.180.10--0.240.240.220.120.290.230.210.280.49
Total Current Liabilities3.893.393.422.932.731.892.461.371.341.183.791.491.321.232.071.651.721.681.981.40
Total Non-current Liabilities*0.550.570.570.600.050.050.040.030.040.020.040.040.090.130.180.230.280.390.400.44
Total Liabilities4.443.963.993.542.771.942.501.401.381.203.831.531.421.362.251.882.002.062.391.83
Retained Earnings(113.38)(107.76)(104.09)(100.62)(97.04)(93.54)(90.94)(87.55)(84.34)(81.87)(79.50)(76.35)(73.90)(71.61)(68.76)(65.76)(62.29)(58.78)(55.59)(51.73)
Total Stockholder Equity68.9374.1177.5578.2230.3628.953.533.816.066.174.507.369.474.857.295.538.5411.6214.3817.87
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue0.240.11------------------------------------
Cost of Revenue0.880.10------------------------------------
Gross Profit(0.64)0.00------------------------------------
Research & Development1.861.291.541.172.111.461.982.061.421.171.131.611.371.621.881.952.191.712.261.39
Selling, General & Admin3.683.03--2.691.611.561.451.241.091.220.940.930.961.301.181.521.371.471.681.16
Total Operating Expenses5.554.32------------------------------------
Operating Income(6.19)(4.32)(4.14)(3.86)(3.72)(3.02)(3.43)(3.30)(2.51)(2.38)(2.07)(2.54)(2.32)(2.92)(3.07)(3.47)(3.56)(3.18)(3.94)(2.55)
Net Income(5.63)(3.67)(3.46)(3.58)(3.50)(2.60)(3.39)(3.21)(2.46)(2.37)(3.15)(2.45)(2.29)(2.85)(3.00)(3.47)(3.51)(3.19)(3.86)(2.56)
Basic EPS(0.08)(0.05)(0.04)(0.07)(0.10)(0.08)(0.19)(0.20)(0.17)(0.17)(0.23)(0.21)(0.25)(0.36)(0.38)(0.49)(0.49)(0.45)----
Diluted EPS(0.08)(0.05)(0.04)(0.07)(0.10)(0.08)(0.19)(0.20)(0.17)(0.17)(0.26)(0.21)(0.25)--------------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(4.99)(5.05)(3.76)(3.84)(2.57)(2.87)(1.69)(2.76)(1.96)(2.42)(1.82)(1.65)(1.85)(3.20)(2.46)(2.95)(3.12)(3.01)(2.89)(2.18)
Capital Expenditures0.140.110.030.010.010.010.010.000.000.01-0.000.030.01--0.000.010.060.020.040.01
Free Cash Flow*(5.13)(5.16)(3.78)(3.85)(2.58)(2.89)(1.70)(2.76)(1.96)(2.43)(1.82)(1.68)(1.86)--(2.46)(2.96)(3.19)(3.02)(2.93)(2.19)
Investing Cash Flow4.475.00(1.53)(44.71)(1.31)(24.83)1.500.141.19(1.28)2.96(2.57)(1.29)2.88(3.75)-0.00(0.06)(0.02)2.96(0.01)
Financing Cash Flow0.02--2.5151.184.7527.812.830.632.072.400.00(0.16)6.72--------------
← Scroll for more columns →

* Derived from reported values